• Join
  • Login
  • Contact

Search abstracts

Physiological based PK modeling - applications to decision making in biopharmaceuticals

  • In: S3 - Improving bioavailability/bioequivalence on Tuesday, 4 September 2007, 9:00-12:00
  • At: Beijing (China) (2007)
  • Type: Presentation
  • By: AHR, Gertrud (Bayer HealthCare AG, Wuppertal, Germany)
  • Co-author(s): Brendel, Erich (Bayer HealthCare AG, Wuppertal, Germany)
    Mueck, Wolfgang (Bayer HealthCare AG, Wuppertal, Germany)
    Willmann, Stefan (Bayer Technology Services, Leverkusen, Germany)
    Lippert, Joerg (Bayer Technology Services, Leverkusen, Germany)
  • Abstract:

    Aim: Physiological based PK modeling (PB/PK)1,2 is available as commercial programs to support decision making in biopharmaceutical development. Application examples are presented how PB/PK may support scientists to compartmentalize their understanding and to divide the process from oral drug intake until drug absorption into the several steps


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses